Form4insider filings, from the source

SEC Form 4 · accession 0001636178-26-000024

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 4, 2026M10,000$117.76A28,876D
Common StockF2Jun 4, 2026S120$539.6393D28,756D
Common StockF3Jun 4, 2026S480$541.1433D28,276D
Common StockF4Jun 4, 2026S440$542.7769D27,836D
Common StockF5Jun 4, 2026S1,086$544.1119D26,750D
Common StockF6Jun 4, 2026S1,545$544.9442D25,205D
Common StockF7Jun 4, 2026S1,129$545.8885D24,076D
Common StockF8Jun 4, 2026S1,033$547.0035D23,043D
Common StockF9Jun 4, 2026S2,749$548.0374D20,294D
Common StockF10Jun 4, 2026S1,298$549.0586D18,996D
Common StockF11Jun 4, 2026S120$550.4767D18,876D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$117.76Jun 4, 2026M10,000DMar 15, 2023Mar 15, 2027Common Stock10,00030,000D

Explanation of responses